Drug profile · INN
tenofovir alafenamide
VEMLIDY
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
tenofovir alafenamide (VEMLIDY) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.
Key facts
INN tenofovir alafenamide
Brand VEMLIDY
Route ORAL
Formulation TABLET
ATC code J05AF13
Originator Sunshine Biopharma
Frequently asked questions
What is tenofovir alafenamide?
tenofovir alafenamide (VEMLIDY) is an FDA-listed pharmaceutical active ingredient. Associated with Sunshine Biopharma. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for tenofovir alafenamide?
VEMLIDY is a marketed brand name for tenofovir alafenamide. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of tenofovir alafenamide?
tenofovir alafenamide has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.